
Aidoc has raised $150M to accelerate development of its CARE foundation model for clinical AI in radiology and beyond.
Key Details
- 1Aidoc secured $150M in funding, bringing total raised to $370M since 2016.
- 2Investors include major U.S. hospital systems and venture capital firms; $40M is a revolving credit line.
- 3Funds will accelerate CARE, a clinical-grade foundation AI model adaptable across diseases.
- 4CARE aims to cover 90% of clinically relevant diseases within three years, including cancer and cardiovascular conditions.
- 5Aidoc supports decision-making for over 45 million patients annually across 150+ health systems.
- 6Company has over 20 FDA clearances and plans significant investment via partnerships with Nvidia and AWS.
Why It Matters

Source
Radiology Business
Related News

Harrison.ai Receives FDA Breakthrough Status for Imaging AI Device
Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.

Experts Call for Stricter FDA Standards in Radiology AI Validation
Dana-Farber experts recommend actionable steps to enhance the rigor and transparency of FDA validation standards for radiology AI software.

FDA Authorizes AI Tool for Detecting Mitral Annular Calcification on Routine CT
Bunkerhill Health receives FDA clearance for an AI model that detects mitral annular calcification (MAC) on routine, non-gated CT scans.